Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). - Wikidata - wikimedia - TriplyDB

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

http://www.wikidata.org/entity/Q37286751

about

Non-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease as a multi-systemic disease Dietary approach in the treatment of nonalcoholic fatty liver disease Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.Non-alcohol fatty liver disease in Asia: Prevention and planning.Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC.Changes in glucose transporter expression and nitric oxide production are associated with liver injury in diabetes.Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.Dietary Modulation of the Epigenome.Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B.Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption.

P2860

Q24563068-15F505D8-23CD-4BC3-85F1-870DAC39040F Q26749290-F5872B24-ABCC-4B10-BCDC-5149BD92E21E Q26777508-C5D0CC48-6622-4134-B173-6A58A4376E22 Q26778035-FBF9857C-8B6B-45DF-872C-3E560E50C308 Q26781477-43E97080-07E8-435B-BFB9-6F6784ADE70E Q33580031-B9306312-9A2C-42ED-BE59-3694F60FBBE2 Q34827519-74155C01-2281-4002-9811-C33D820DB5B5 Q35561941-9DF95D9C-60B6-4285-81EE-07FE93396D9A Q35819344-B64BC8BF-FF98-4E1F-AFC2-632FAFE8FA5C Q35860576-004728FA-0DD9-4FD3-8FAD-7FC67BD2506B Q36656622-D80BCEC2-2F99-44BA-99D3-C41CE6381BC1 Q38261236-28F26F96-EF72-4E1D-9C37-58729D59BE83 Q39044073-3EA64D45-6859-4BB9-A445-C42826283944 Q39468081-C3CDA876-7D4F-42BC-A611-98ABB6E8C9E7 Q40564967-AA294C33-2C8F-40B5-9405-D02CAB1EE64C Q47192103-514FA929-638D-4AEC-B2B1-798422BA97E7 Q50014666-7630D7E0-3328-483C-BEA3-DD727FD445CE Q51245978-1FD1D889-D4BA-4E23-9AC3-D89787600B18 Q53625645-76EBAA5C-F1A5-47E8-B023-75E0E330C92D Q55315063-81C91639-8EF9-49A8-A1FE-8159CDA62F3E

P2860

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

http://www.wikidata.org/entity/Q37286751

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

@en

Nutritional management of insulin resistance in nonalcoholic fatty liver disease

@nl

type

label

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

@en

Nutritional management of insulin resistance in nonalcoholic fatty liver disease

@nl

prefLabel

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

@en

Nutritional management of insulin resistance in nonalcoholic fatty liver disease

@nl

P1433

Q37286751-6676A07B-63B8-47A7-A396-07898ED0385A

P1476

Q37286751-C18AC5F4-C530-4420-AF50-6527D58712EA

P2093

Q37286751-4ED484CC-EE2C-46C5-B94B-06CCA27D519E

Q37286751-5C8D58BC-88AF-4DC0-BAEE-21C47F3468FC

Q37286751-7F1BA20E-29A9-45DC-8B05-5FA93C9AD3B1

P275

Q37286751-0C7BCF8A-0D42-4061-81CC-6FCEFA0878CF

P2860

Q37286751-0470EC73-5E1F-4952-AD8C-0B759FDDFE05

Q37286751-0885F897-DFE4-4A6A-BAA2-2ABF1955A777

Q37286751-0EDB00FF-7A4D-4A6A-87CD-E2C8D93280CE

Q37286751-107A71A2-B4BA-4FD0-9418-2E21E2560A5C

Q37286751-18C775A2-2CDE-4D5C-A988-CB13AAD8E26A

Q37286751-1C03DF20-D6B7-40C3-B99A-8A56C4D42733

Q37286751-1D0ABFD4-A2D3-48F3-A552-537AAA8205C1

Q37286751-1D6B563F-B041-4A40-A0E6-CF6D5617D056

Q37286751-1E1E719D-3DC4-4416-84F6-950F9AE34E40

Q37286751-1E9DE86A-C5E7-4E86-95BD-2A3E81DAD970

P304

Q37286751-AE391237-0E2E-4FCB-8ED5-8CE6CF890664

P31

Q37286751-14AB002D-169F-464A-B6D0-42DE60A51E3B

Q37286751-910BFC12-64F8-4D3B-ACC8-C999B6B28892

P356

Q37286751-DBA4AF60-6B57-4E37-B22D-8AE10596D6A8

P433

Q37286751-4FB26D73-AF8A-42B3-A10B-8D43DDA0362F

P478

Q37286751-3E2E0AE1-A858-482E-A428-B50B471B46DA

P50

Q37286751-8B7CDE35-B7E6-4248-9E38-0E21C2FEF237

Q37286751-9188E876-3336-4AD7-B2FD-0BC670F2964E

P5008

Q37286751-5A5DFE8D-8855-449D-B4AF-00246EBF4437

P577

Q37286751-07A71FB6-90E4-4191-AC4B-B1ADD8085777

P5875

Q37286751-8C14E5CD-31E6-4D56-B0B4-004710A0D603

P698

Q37286751-C866BC6A-B65E-4EDD-9011-D24830726A92

P921

Q37286751-298129C7-F25B-4743-85EB-A2BC17E4385C

Q37286751-7BC547F9-00AF-4FE2-B6FD-479BD7433513

P932

Q37286751-DF718F42-4869-4920-9E4B-50B8ABDFC1F9

P356

P1433

P1476

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

@en

P2093

Beth A Conlon

http://www.w3.org/2001/XMLSchema#string

Karin Aebersold

http://www.w3.org/2001/XMLSchema#string

Sunil S Jhangiani

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Low glycaemic index, or low glycaemic load, diets for diabetes mellitus

Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis

Redox mechanisms in hepatic chronic wound healing and fibrogenesis

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

Health effects of low-carbohydrate diets: where should new research go?

Vitamin E and nonalcoholic fatty liver disease

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

Steatohepatitis: a tale of two "hits"?

P304

4093-4114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/NU5104093

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Judith Wylie-Rosett

Jeannette M Beasley

P5008

P577

2013-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258038655

http://www.w3.org/2001/XMLSchema#string

P698

24152749

http://www.w3.org/2001/XMLSchema#string

P921

fatty liver disease

P932

3820061

http://www.w3.org/2001/XMLSchema#string